Delivery Order SPE2DB20D6037-SPE2DB24FTVC2
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,844.60 contract is for the delivery of Alfuzosin Hydrochloride, a pharmaceutical product, with a completion date of March 21, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Alfuzosin Hydrochlo medical supplies, with a ceiling value of $5,844.60 and an ultimate completion date of July 18, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a $5,844.60 firm fixed-price delivery order for Alfuzosin Hydrochloride by the Defense Logistics Agency's Medical Supply Chain division. The contract, issued on September 8, 2025, with an ultimate completion date of September 18, 2025, represents a direct supply action under the company's larger Indefinite Delivery Contract (IDC) with the DLA. No set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,723.68 by the Defense Logistics Agency on August 26, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (1,000 units). This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, represents a single transaction under the company's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $3,848.60 issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract provides for the delivery of 4,565,252,933 tablets of the generic drug Tamsulosin Hydrochloride 0.4 mg to the DLA by July 23, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,458.40, is for the delivery of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $10,239.16, is for the delivery of a variety of pharmaceutical products, including prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities. The contract is part of the DLA's Medical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at up to $45,597.60 and has an ultimate completion date of October 7, 2020. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $25,135.40 contract is for the delivery of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $109,727.44, is for the delivery of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc....
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB24FTVC2Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,449.52, is for the delivery of Alfuzosin Hydrochloride Extended-Release 10 mg tablets. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group provides both routine and critical medications to DoD healthcare facilities through this vehicle, solidifying its position as a crucial supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 4/9/24 |